Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $65.25, for a total value of $2,283,750.00. Following the completion of the sale, the director now owns 6,209 shares of the company’s stock, valued at $405,137.25. This trade represents a 84.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Thursday, January 23rd, Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock. The shares were sold at an average price of $65.12, for a total value of $682,783.20.
- On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.35, for a total value of $2,322,250.00.
- On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.15, for a total transaction of $2,350,250.00.
- On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
- On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96.
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total value of $5,915.00.
- On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total value of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00.
Ryan Specialty Price Performance
Shares of NYSE:RYAN opened at $66.62 on Friday. The stock has a market capitalization of $17.44 billion, a P/E ratio of 86.52, a P/E/G ratio of 1.14 and a beta of 0.72. The business has a 50-day moving average of $66.93 and a two-hundred day moving average of $66.40. Ryan Specialty Holdings, Inc. has a fifty-two week low of $42.21 and a fifty-two week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.
Analyst Upgrades and Downgrades
A number of research firms have recently issued reports on RYAN. Bank of America increased their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Barclays lifted their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Wells Fargo & Company reduced their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 14th. Finally, The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of “Hold” and an average target price of $74.40.
Read Our Latest Report on RYAN
Institutional Trading of Ryan Specialty
Institutional investors and hedge funds have recently modified their holdings of the company. Signaturefd LLC boosted its stake in Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after purchasing an additional 148 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after buying an additional 190 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Ryan Specialty by 5.2% in the third quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock valued at $347,000 after acquiring an additional 256 shares during the period. Loomis Sayles & Co. L P grew its stake in shares of Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after acquiring an additional 286 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its position in Ryan Specialty by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock worth $755,000 after acquiring an additional 295 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- ESG Stocks, What Investors Should Know
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Which Wall Street Analysts are the Most Accurate?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- With Risk Tolerance, One Size Does Not Fit All
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.